Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chugai Pharmaceutical
Pharma
FDA approves Verastem's combo for rare form of ovarian cancer
Verastem has gained its first FDA approval, winning an accelerated nod for the combo therapy to treat a rare form of ovarian cancer.
Kevin Dunleavy
May 9, 2025 10:42am
Roche's answer to AstraZeneca PNH drugs nabs China nod
Feb 8, 2024 11:02am
Roche sues Biogen over Actemra biosimilar infringement claims
Jul 17, 2023 9:45am
Roche's Chugai pays $25M to access subcutaneous delivery tech
Mar 29, 2022 8:05am
Taiho, Otsuka, Chugai, Biocon and Mark Alles—FiercePharmaAsia
Jan 10, 2020 10:59am
Chugai promises no supply interruption of cancer drug
Sep 1, 2016 7:53am
